Pharmaceutical Registration in the Dominican Republic: DIGEMAPS and the Simplified Route

The Dominican Republic is the largest economy in the Caribbean and one of the more accessible entry points in the region, which makes it a sensible first Caribbean filing for most exporters.

It has something genuinely useful that most of its neighbours do not: a simplified registration route for a defined list of products, running noticeably faster than the standard path. If your product qualifies, that changes the arithmetic of entry.

The market also has a shape worth understanding before you plan. Public provision, private insurance and a substantial medical tourism sector coexist, and they buy differently — the product that wins a public tender is often not the one a private clinic in Punta Cana wants on its shelf.

Medicines are regulated by DIGEMAPS — Dirección General de Medicamentos, Alimentos y Productos Sanitarios, within the Ministry of Public Health.

DIGEMAPS was established by Decree 82-15 in 2015, consolidating regulatory functions that had previously been more dispersed, with registration and import rules substantially set out in Decree 246-06.

DIGEMAPS handles sanitary registration, establishment authorisation, import control and post-market surveillance. Practically, the fact that the framework rests on identifiable decrees is helpful — there is a documented basis to work from, which is not true everywhere in the Caribbean.

The Dominican Republic requires a single local authorised representative. One responsible party, locally established, answerable to DIGEMAPS.

The word "single" is doing real work. You cannot spread the relationship across several partners to keep any one of them from accumulating leverage — a strategy exporters sometimes use elsewhere. One entity holds it.

That makes the choice consequential and worth slowing down for. The usual options apply: your distributor, your own local entity, or an independent regulatory representative who holds the registration while you appoint distributors commercially. The third route costs more and is chosen less often than it should be in markets where the representative must be singular.

Settle transfer terms in writing at the start. Moving a registration between representatives is possible but neither instant nor friction-free, and the moment you want to do it is exactly the moment cooperation is least likely.

Expect the standard technical and administrative set:

• CoPP in WHO format, legalised for use in the Dominican Republic.
• GMP certificate and manufacturing licence.
• Finished product specification and validated method of analysis.
• Batch Certificate of Analysis.
• Stability data for a tropical, humid, hurricane-belt climate. Warehousing conditions on the island are part of the real-world storage picture, not only the transit.
• Bioequivalence data where required.
• Spanish labelling, artwork and patient information.
• Legalised power of attorney appointing the authorised representative.

Requirements are periodically updated. Confirm the current set with DIGEMAPS before compiling.

The simplified registration procedure is the headline. A defined list of pharmaceutical products can be registered under a reduced-requirement route intended to cut both documentation and time — reported at around four months against roughly six to seven for a new standard application.

Two to three months is a material difference, and the first question on any Dominican project should be whether your product is on that list. It is a cheap question to ask and an expensive one to skip.

Beyond that, the general reliance picture applies. The Pan American Health Organization designates eight Regional Reference Regulatory Authorities — ANMAT, ANVISA, Health Canada, ISP, INVIMA, CECMED, US FDA and COFEPRIS. Geography and trade both favour two of them here: US FDA approval carries weight given DR-CAFTA and the closeness of the US market, and COFEPRIS is relevant given Mexican pharmaceutical presence across the Caribbean.

Confirm current eligibility and the applicable product list with DIGEMAPS rather than assuming your category qualifies.

Reported timelines — roughly six to seven months for a new standard registration, around four for the simplified route — are more concrete than in most regional markets, which helps planning. Treat them as indicative rather than guaranteed, and confirm current figures.

As everywhere, deficiency cycles are what actually stretch a timeline. A complete first submission is worth more than an early one.

Registrations run for a fixed term and require renewal. Track renewal dates from the moment of approval, not from the reminder that may never come.

Foreign documents need authentication before DIGEMAPS will accept them.

The Dominican Republic is a party to the Hague Apostille Convention, as is India, so apostille rather than full consular legalisation will generally apply to public documents. Confirm the current position before arranging consular appointments.

Recurring issues:

• CoPP validity expiring before filing completes.
• Commercial documents requiring notarisation to qualify for apostille.
• Certified Spanish translation to local formal requirements.
• Exact name consistency across CoPP, GMP certificate, licence and power of attorney.

Exceptional import mechanisms cover the usual situations — no registered equivalent, shortage or supply interruption, public health need, orphan products, and clinical trial material under its own route.

Hurricane season gives the Dominican Republic a specific and recurring version of this. Storm damage, supply interruption and emergency health needs create genuine demand for rapid unregistered import, and the authorities have mechanisms to authorise it.

If you intend to be useful in those situations, the preparation is not regulatory paperwork — it is having documentation ready to send at short notice, and having thought in advance about how goods reach an island whose ports and airports may themselves be disrupted. Suppliers who start assembling documents when the emergency is announced are not the ones who help.

The standard conditions still apply: authorisation is per consignment against a justification, the importing party applies, and it is not a route around registration for continuous supply.

Confirm current conditions with DIGEMAPS.

An unregistered medicine may be imported for an individually identified patient, on a treating physician's responsibility, where no suitable registered alternative exists.

Typically required: prescription naming the patient, clinical justification, authority authorisation before shipment, quantity limited to the treatment course, batch CoA and provenance.

Compassionate use and expanded access for clinical-stage products sit under their own framework.

The Dominican Republic has an unusual driver here: a significant medical tourism sector, and a large diaspora moving between the island and the United States. Both generate requests for therapies that are familiar in North America but not registered locally — often from well-informed patients and physicians who know exactly what they want and why.

Logistics are comparatively favourable. Santo Domingo and Punta Cana have good North American and European connections and the cold chain infrastructure serving the tourism and private healthcare sectors is better than the country's income level would suggest.

Further reading: our global guide to named patient import programmes, our named patient supply service, and our cold chain logistics page.

Public demand runs through the Ministry of Public Health and the public health service network, with the national health insurance system (SeNaSa) covering a large share of the population and shaping what gets reimbursed. Public procurement is centralised for significant volumes.

A valid registration is generally required to bid, which makes the simplified route commercially interesting beyond the time saving — it can shorten the gap between deciding to enter and being able to participate at all.

The private and medical tourism channels operate on different logic. Private clinics serving international patients often want specific brands and presentations, are less price-driven than public procurement, and make decisions faster. A portfolio built only for public tender may miss that entirely.

The PAHO Strategic Fund is available as a parallel route, with eligibility resting on WHO Prequalification at tender opening or approval by regulatory authorities of regional reference rather than separate national registration. Confirm current criteria with PAHO.

Our government and institutional tender supply page covers the technical file.

The Dominican Republic has one more rung on this ladder than most of its neighbours, and it is the one worth checking first.

Establish simplified-route eligibility before you build anything. It is the single highest-value question on a Dominican project, it takes one conversation, and companies routinely assemble a full standard dossier without ever having asked it.

• Never checking simplified-route eligibility, then paying for the full path unnecessarily.
• Authorised representative chosen casually in a market that permits only one.
• No agreed transfer terms, discovered at the point the relationship is already failing.
• Stability data that ignores humid tropical storage, including local warehousing conditions.
• Expired or mismatched certificates.
• A portfolio built only for public tender, missing the private and medical tourism channels entirely.

Ask about the simplified route in your first conversation. Nothing else on a Dominican project has that ratio of value to effort.

Take the authorised representative decision seriously — the rules allow you exactly one, so the usual hedging strategies are unavailable and the terms carry more weight.

Segment your commercial thinking. Public tender, private insurance and medical tourism are three different buyers on one island, and a plan that treats them as one market will underperform against all three.

If you already hold FDA approval, use it. Proximity and DR-CAFTA both work in your favour.

And if you want to be useful in emergencies, get your documentation ready before the season, not during it.

Not legal advice. Confirm current requirements with DIGEMAPS and take local advice before committing funds.